Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Presence of Waddlia chondrophila in hot water systems from non-domestic buildings in France.

Agustí G, Le Calvez T, Trouilhé MC, Humeau P, Codony F.

J Water Health. 2018 Feb;16(1):44-48. doi: 10.2166/wh.2017.106.

PMID:
29424717
2.

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.

Calvez T, Chambost H, d'Oiron R, Dalibard V, Demiguel V, Doncarli A, Gruel Y, Huguenin Y, Lutz P, Rothschild C, Vinciguerra C, Goudemand J; for FranceCoag Collaborators.

Haematologica. 2018 Jan;103(1):179-189. doi: 10.3324/haematol.2017.174706. Epub 2017 Oct 12.

3.

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product.

Calvez T, Chambost H, Lutz P, Rothschild C, Goudemand J.

Blood. 2015 Jun 11;125(24):3817-9. doi: 10.1182/blood-2015-02-622167. No abstract available.

4.

EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.

Polack B, Calvez T, Chambost H, Rothschild C, Goudemand J, Claeyssens S, Borel-Derlon A, Bardoulat I, Maurel F, Woronoff-Lemsi MC; EQOFIX Study Group.

Transfusion. 2015 Jul;55(7):1787-97. doi: 10.1111/trf.13016. Epub 2015 Feb 5.

PMID:
25652955
5.

Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.

Calvez T, Chambost H, Claeyssens-Donadel S, d'Oiron R, Goulet V, Guillet B, Héritier V, Milien V, Rothschild C, Roussel-Robert V, Vinciguerra C, Goudemand J; FranceCoag Network.

Blood. 2014 Nov 27;124(23):3398-408. doi: 10.1182/blood-2014-07-586347. Epub 2014 Sep 24.

6.

In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.

Pashov AD, Calvez T, Gilardin L, Maillère B, Repessé Y, Oldenburg J, Pavlova A, Kaveri SV, Lacroix-Desmazes S.

Haemophilia. 2014 Mar;20(2):176-84. doi: 10.1111/hae.12276. Epub 2013 Oct 14.

PMID:
24118514
7.

PHYMYCO-DB: a curated database for analyses of fungal diversity and evolution.

Mahé S, Duhamel M, Le Calvez T, Guillot L, Sarbu L, Bretaudeau A, Collin O, Dufresne A, Kiers ET, Vandenkoornhuyse P.

PLoS One. 2012;7(9):e43117. doi: 10.1371/journal.pone.0043117. Epub 2012 Sep 13.

8.

Detection of free-living amoebae by using multiplex quantitative PCR.

Le Calvez T, Trouilhé MC, Humeau P, Moletta-Denat M, Frère J, Héchard Y.

Mol Cell Probes. 2012 Jun;26(3):116-20. doi: 10.1016/j.mcp.2012.03.003. Epub 2012 Mar 17.

PMID:
22449586
9.

Reduced maternal mortality in Tunisia and voluntary commitment to gender-related concerns.

Farhat EB, Chaouch M, Chelli H, Gara MF, Boukraa N, Garbouj M, Hamrouni M, Fourati A, Calvez T, Thonneau P.

Int J Gynaecol Obstet. 2012 Feb;116(2):165-8. doi: 10.1016/j.ijgo.2011.10.010. Epub 2011 Nov 17.

PMID:
22098789
10.

Proteolytic antibodies activate factor IX in patients with acquired hemophilia.

Wootla B, Christophe OD, Mahendra A, Dimitrov JD, Repessé Y, Ollivier V, Friboulet A, Borel-Derlon A, Levesque H, Borg JY, Andre S, Bayry J, Calvez T, Kaveri SV, Lacroix-Desmazes S.

Blood. 2011 Feb 17;117(7):2257-64. doi: 10.1182/blood-2010-07-296103. Epub 2010 Dec 3.

11.

Working conditions and psychosocial risk factors of employees in French electricity and gas company customer support departments.

Chevalier A, Dessery M, Boursier MF, Grizon MC, Jayet C, Reymond C, Thiebot M, Zeme-Ramirez M, Calvez T.

Int Arch Occup Environ Health. 2011 Jan;84(1):7-18. doi: 10.1007/s00420-010-0595-2. Epub 2010 Nov 17.

PMID:
21082190
12.

Fungal diversity in deep-sea hydrothermal ecosystems.

Le Calvez T, Burgaud G, Mahé S, Barbier G, Vandenkoornhuyse P.

Appl Environ Microbiol. 2009 Oct;75(20):6415-21. doi: 10.1128/AEM.00653-09. Epub 2009 Jul 24.

13.

Ethics and observational studies in medical research: various rules in a common framework.

Claudot F, Alla F, Fresson J, Calvez T, Coudane H, Bonaïti-Pellié C.

Int J Epidemiol. 2009 Aug;38(4):1104-8. doi: 10.1093/ije/dyp164. Epub 2009 Mar 31.

14.

Diversity of culturable marine filamentous fungi from deep-sea hydrothermal vents.

Burgaud G, Le Calvez T, Arzur D, Vandenkoornhuyse P, Barbier G.

Environ Microbiol. 2009 Jun;11(6):1588-600. doi: 10.1111/j.1462-2920.2009.01886.x. Epub 2009 Feb 23.

PMID:
19239486
15.
16.

Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort.

Chambost H, Doncarli A, Bertrand MA, Briquel ME, Gay V, Pincemaille O, Trossaert M, Calvez T; for FranceCoag Network group.

Haemophilia. 2007 Nov;13(6):712-21.

PMID:
17973847
17.
18.

Introduction of an obstetric health information system: results of a pilot study in North Cameroon.

Dongmo R, Fenieys D, Aminou M, Calvez T, Gruénais ME, Thonneau P.

Rev Epidemiol Sante Publique. 2006 Dec;54(6):507-15.

PMID:
17194982
19.

Risk of inhibitors in haemophilia and the type of factor replacement.

Goudemand J, Laurian Y, Calvez T.

Curr Opin Hematol. 2006 Sep;13(5):316-22. Review.

PMID:
16888435
20.

Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required.

Calvez T, Laurian Y.

Br J Haematol. 2006 Mar;132(6):798-800; author reply 800-1. No abstract available.

PMID:
16487187
21.

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.

Goudemand J, Rothschild C, Demiguel V, Vinciguerrat C, Lambert T, Chambost H, Borel-Derlon A, Claeyssens S, Laurian Y, Calvez T; FVIII-LFB and Recombinant FVIII study groups.

Blood. 2006 Jan 1;107(1):46-51. Epub 2005 Sep 15.

22.

Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death.

Stieltjes N, Calvez T, Demiguel V, Torchet MF, Briquel ME, Fressinaud E, Claeyssens S, Coatmelec B, Chambost H; French ICH Study Group.

Haemophilia. 2005 Sep;11(5):452-8.

PMID:
16128887
23.

Mortality of workers exposed to ionizing radiation at the French National Electricity Company.

Rogel A, Carré N, Amoros E, Bonnet-Belfais M, Goldberg M, Imbernon E, Calvez T, Hill C.

Am J Ind Med. 2005 Jan;47(1):72-82.

PMID:
15597358
24.

[Proposed law on protection of personal rights concerning personal information. Position of the French National Civil Rights Commission (CCTIR)].

Bara C, Berr C, Blacher J, Bloch J, Bonaïti C, Calvez T, Delpech M, Epelboin S, Eschwege E, Falissard B, Leplege A, Mayaux MJ, Perez P, Piedbois P, Seror V; Comité Consultatif sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé.

Rev Epidemiol Sante Publique. 2003 Jun;51(3):364-67. French. No abstract available.

PMID:
14506800
25.

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.

Brussel A, Mathez D, Broche-Pierre S, Lancar R, Calvez T, Sonigo P, Leibowitch J.

AIDS. 2003 Mar 28;17(5):645-52.

PMID:
12646786
26.

What factors influence the age at diagnosis of hemophilia? Results of the French hemophilia cohort.

Chambost H, Gaboulaud V, Coatmélec B, Rafowicz A, Schneider P, Calvez T; Suivi thérapeutique National des Hémophiles (SNH) Group.

J Pediatr. 2002 Oct;141(4):548-52.

PMID:
12378196
27.

Ectopic pregnancy in Conakry, Guinea.

Thonneau P, Hijazi Y, Goyaux N, Calvez T, Keita N.

Bull World Health Organ. 2002;80(5):365-70.

28.

The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system.

Calvez T, Biou M, Costagliola D, Jullien AM, Laurian Y, Rossi F, Rothschild C, Sié P; Suivi Thérapeutique National des Hémophiles Group.

Haemophilia. 2001 Jan;7(1):82-8.

PMID:
11136385
29.

[Obstetric complications of the first trimester in Western Africa].

Goyaux N, Calvez T, Yace-Soumah F, Welfens-Ekra C, Faye O, De Bernis L, Diadhiou F, Goufodji M, Alihonou E, Carre N, Thonneau P.

J Gynecol Obstet Biol Reprod (Paris). 1998 Nov;27(7):702-7. French.

30.

Prevalence and determinants of current contraceptive method use in a palm oil company in Cameroon.

Ekani-Bessala MM, Carre N, Calvez T, Thonneau P.

Contraception. 1998 Jul;58(1):29-34.

PMID:
9743893
31.

[Risk of the appearance of inhibitors linked to the administration of factors VIII and IX. Review of the literature].

Calvez T, Costagliola D.

Transfus Clin Biol. 1994;1(6):427-35. Review. French.

PMID:
7881588
32.

Randomized study of two doses of didanosine in children infected with human immunodeficiency virus.

Blanche S, Calvez T, Rouzioux C, Ortigao MB, Taburet AM, Ferroni A, Debre M, Wintrebert F, Singlas E, Costagliola D, et al.

J Pediatr. 1993 Jun;122(6):966-73.

PMID:
8501579

Supplemental Content

Loading ...
Support Center